|
|
Volumn 8 Suppl 1, Issue , 2006, Pages
|
|
Toxicities of antiangiogenic therapy in non-small-cell lung cancer.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
BENZENESULFONIC ACID DERIVATIVE;
BEVACIZUMAB;
INDOLE DERIVATIVE;
MONOCLONAL ANTIBODY;
N (4 BROMO 2 FLUOROPHENYL) 6 METHOXY 7 ((1 METHYLPIPERIDIN 4 YL)METHOXY)QUINAZOLIN 4 AMINE;
N-(4-BROMO-2-FLUOROPHENYL)-6-METHOXY-7-((1-METHYLPIPERIDIN-4-YL)METHOXY)QUINAZOLIN-4-AMINE;
PIPERIDINE DERIVATIVE;
PYRIDINE DERIVATIVE;
PYRROLE DERIVATIVE;
QUINAZOLINE DERIVATIVE;
SORAFENIB;
SUNITINIB;
UNCLASSIFIED DRUG;
VASCULOTROPIN;
DRUG ANTAGONISM;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
REVIEW;
SQUAMOUS CELL CARCINOMA;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
BENZENESULFONATES;
CARCINOMA, NON-SMALL-CELL LUNG;
CARCINOMA, SQUAMOUS CELL;
HUMANS;
INDOLES;
LUNG NEOPLASMS;
PIPERIDINES;
PYRIDINES;
PYRROLES;
QUINAZOLINES;
VASCULAR ENDOTHELIAL GROWTH FACTORS;
MLCS;
MLOWN;
|
|
EID: 34249686689
PISSN: 15257304
EISSN: None
Source Type: Journal
DOI: 10.3816/CLC.2006.s.010 Document Type: Article |
|
Times cited : (44)
|
|
References (29)
|
